Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cardio Diagnostics Holdings Inc. - Common stock
(NQ:
CDIO
)
0.4682
+0.0022 (+0.47%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cardio Diagnostics Holdings Inc. - Common stock
< Previous
1
2
3
Next >
Family Medicine Specialists Selects Cardio Diagnostics’ Epigenetic-Genetic Tests for Assessing Heart Attack Risk for its BlueCross BlueShield Patients
November 07, 2023
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Cardio Diagnostics Leverages AI To Combat Cardiovascular Disease
October 31, 2023
By Jeremy Golden, Benzinga
Via
TheNewswire.com
Topics
Artificial Intelligence
Death
Exposures
Artificial Intelligence
Death
Cardio Diagnostics Holdings, Inc Receives Innovative Technology Contract from Vizient for Its Novel AI-Driven Precision Heart Disease Tests – Epi+Gen CHD & PrecisionCHD
October 31, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Holdings, Inc and Aimil Ltd Join Forces to Introduce Cardiovascular Epigenetic Technologies to India
October 17, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Holdings, Inc Launches New Lab and Fulfillment Center, Paving Way for Expanded Testing Capacity, Reduced Costs, Reduced Turnaround Time and Improved Margins
October 12, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Publishes Novel and Scalable Pathways to Enhance Global Coronary Heart Disease Care through Precision Epigenetics in Epigenomics
September 20, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Holdings, Inc. and Truckers Health Network Enter Into a Strategic Collaboration to Accelerate Cardiovascular Health Initiatives in the Trucking Industry
September 07, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Holdings, Inc Partners with Ascension Borgess Hospital’s Heart Attack Prevention Clinic on Coronary Artery Disease Study
September 06, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Holdings, Inc to Participate in Upcoming Investor Conferences
September 05, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Partners With FRSTeam of East Kansas and West Missouri to Host First Onsite Heart Disease Fair in Kansas Using Epigenetic-Genetic Technologies
August 18, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Holdings, Inc Announces Expansion of IP Portfolio in Australia with Notice of Allowance of Patent Application
August 02, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Holdings, Inc and RiverRock Medical Partner to Bring Epigenetic-Genetic Heart Disease Testing to Austin, Texas
July 06, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Holdings, Inc Democratizes CHD Detection with Nationwide Launch of PrecisionCHD™
June 21, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Publishes Research Highlighting the Reversibility of Epigenetic Signatures of Coronary Heart Disease
June 13, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Holdings, Inc’s Actionable Clinical IntelligenceTM (ACI) Platform Offers New Epigenetic and Genetic Insights to Inform Coronary Heart Disease Management
May 16, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Transforming Heart Disease Prevention for Self-Insured Employers in Oklahoma, Missouri, Kansas, and Arkansas: A Strategic Alliance between Connect Clinic and Cardio Diagnostics
May 10, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Holdings, Inc Unveils The CardioInnovate360TM BioPharma Research System
May 04, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Juniper Research Awards Cardio Diagnostics Holdings, Inc Future Digital Award for Best Digital Diagnostics Solution
April 26, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Holdings, Inc to Attend 22nd Annual AHOU Conference
April 12, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Holdings, Inc Announces Strategic Engagement with Lifespan.io to Drive Longevity & Heart Disease Research and Education
April 05, 2023
From
Cardio Diagnostics
Via
Business Wire
Cardio Diagnostics Holdings, Inc Sponsors Becker’s Hospital Review 13th Annual Meeting
March 29, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Holdings, Inc Announces Financing Agreement with Yorkville Advisors Global, LP of up to $11.2 Million
March 08, 2023
From
Cardio Diagnostics
Via
Business Wire
Cardio Diagnostics Holdings, Inc Welcomes Dr. Damon Broyles, MD, as Strategic Advisor for Precision Cardiovascular Medicine Strategy
March 08, 2023
From
Cardio Diagnostics Holdings, Inc
Via
Business Wire
Cardio Diagnostics Holdings Inc Announces Expansion of IP Portfolio with Notice of Allowance of Patent Application
March 02, 2023
From
Cardio Diagnostics Holdings Inc
Via
Business Wire
Cardio Diagnostics (NASDAQ: CDIO) Unveils Innovative Blood Test to Detect Early Stages of Coronary Heart Disease
February 28, 2023
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) is engaged as an artificial intelligence-driven precision cardiovascular medicine company, which is focused on
Via
Spotlight Growth
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cardio Diagnostics Holdings Inc Launches Revolutionary Blood Test for Early Detection of Coronary Heart Disease
February 28, 2023
From
Cardio Diagnostics Holdings Inc
Via
Business Wire
Cardio Diagnostics Holdings Inc to Debut PrecisionCHD™ at the American College of Cardiology’s 72nd Annual Scientific Session
February 22, 2023
From
Cardio Diagnostics Holdings Inc
Via
Business Wire
Healing Sanctuary Clinic Partners With Cardio Diagnostics Holdings Inc to Offer the Epi+Gen CHD Test in their Medical Practice in Idaho
January 05, 2023
From
Cardio Diagnostics Holdings Inc
Via
Business Wire
Cardio Diagnostics Holdings Inc to Attend 41st Annual JP Morgan Healthcare Conference
January 04, 2023
From
Cardio Diagnostics Holdings Inc
Via
Business Wire
Houston Concierge Medicine Partners With Cardio Diagnostics to Offer the Epi+Gen CHD Test in Their Executive Health Program
December 28, 2022
From
Cardio Diagnostics Holdings Inc
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.